News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
Algernon Pharmaceuticals Announces Positive Feedback from U.S. FDA for Phase 1 Ifenprodil Small Cell Lung Cancer Study
Algernon Pharmaceuticals
Blackhawk Growth Enters into Credit Facility for up to $10 Million
MindBio Therapeutics
Psyched Wellness Appoints Chief Commercial Officer to Lead Sales and Marketing of AME-1 and Launch CPG Products
Psyched Wellness
NeonMind Announces Successful Completion of Pre-IND Consultation with FDA on Clinical Path for Obesity Drug Candidate NEO-001
NeonMind Biosciences Inc.
Ryan Moss | Director of Research, Filament Health
Filament Health
Clearmind Medicine to Pursue Dual Listing on Nasdaq
Clearmind Medicine
Algernon Announces Positive Feedback on its Planned Phase 1/2a DMT Human Stroke Study
Algernon Pharmaceuticals
PsyBio Therapeutics Furthers Intellectual Property Portfolio with Six New Manufacturing Patent Applications
PsyBio Therapeutics
Enveric Biosciences Announces Positive Preclinical Data for EV102 Radiodermatitis Drug Candidate
Enveric Biosciences
Filament Health Announces Co-Development and Exclusive Licensing Agreement with Entheotech Bioscience
Filament Health
PharmaDrug Provides Research Results and Initiates IND-Enabling Studies for Cepharanthine in the Treatment of Multiple Cancers
Pharmadrug Inc.
Clearmind Medicine Engages Bar-Ilan University to Evaluate Anti-Addictive Properties of Clearmind's Proprietary MEAI Compound
Clearmind Medicine
Daniel Clauw | Scientific Advisor, Tryp Therapeutics
Tryp Therapeutics
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.